Health & Biotech
Health & Biotech
Cancer fighter Race Oncology is now a 8-bagger in the last 12 months
Health & Biotech
MGC Pharma scoops major Israeli partnership for epilepsy drug
Health & Biotech
No marijuana is ok for pregnant women, not even for morning sickness
Health & Biotech
Cann Global back on ASX as Laos partner claims $US6.1m in dispute
Health & Biotech
eSense shifts gears into cosmeceuticals with Aussie tie-up
Health & Biotech
User growth is still climbing, but a price war may be heating up in Australia’s cannabis market
Health & Biotech
Think that person has an infectious hack? You’re probably wrong
Health & Biotech
StockDoc Podcast: Data clarity drives better healthcare outcomes, Mach7 has the solution
Health & Biotech
Creso Pharma’s Canadian retail sales set to start
Health & Biotech
Large caps deny they’re being outgunned by smaller peers in health R&D
Health & Biotech
Weed Week: Moves are afoot in the US to fix a cannabis ‘scheduling’ clash
Health & Biotech
Health Kick: This stock has a clear vision for the future of contact lenses
Health & Biotech
Check up: Sometimes no news is good news
Health & Biotech
What’s Opthea eyeing now that it has two successful trials under its belt?
Health & Biotech
Opthea’s done it again: Its drug passed its DME clinical trial
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.